Does REVATIO Cause Pulmonary hypertension? 44 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 44 reports of Pulmonary hypertension have been filed in association with REVATIO. This represents 10.1% of all adverse event reports for REVATIO.
44
Reports of Pulmonary hypertension with REVATIO
10.1%
of all REVATIO reports
39
Deaths
10
Hospitalizations
How Dangerous Is Pulmonary hypertension From REVATIO?
Of the 44 reports, 39 (88.6%) resulted in death, 10 (22.7%) required hospitalization, and 1 (2.3%) were considered life-threatening.
Is Pulmonary hypertension Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for REVATIO. However, 44 reports have been filed with the FAERS database.
What Other Side Effects Does REVATIO Cause?
Death (79)
Dyspnoea (41)
Cardiac failure (26)
Fall (21)
Pneumonia (20)
Malaise (17)
Cardiac disorder (14)
Respiratory failure (13)
Fluid retention (11)
Hypotension (10)
What Other Drugs Cause Pulmonary hypertension?
TREPROSTINIL (1,931)
MACITENTAN (1,505)
AMBRISENTAN (1,504)
SELEXIPAG (681)
EPOPROSTENOL (591)
SILDENAFIL (517)
BOSENTAN (504)
TADALAFIL (428)
RIOCIGUAT (411)
ADALIMUMAB (287)
Which REVATIO Alternatives Have Lower Pulmonary hypertension Risk?
REVATIO vs REVEFENACIN
REVATIO vs REVLIMID
REVATIO vs REVOLADE
REVATIO vs REVUMENIB
REVATIO vs REYATAZ